小檗碱类似物7i的抗肿瘤活性及其机制的初步研究

来源 :2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会 | 被引量 : 0次 | 上传用户:Michaelyfj
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths.Patient derived xenografts (PDX),generated by direct engraftment of tumor
会议
Objective: To explore the role of epithelial-mesenchymal transition(EMT) in the acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung ca
Objective: The cyclin-dependent kinase inhibitor 1A (CDKN1A), p21/Cipl, is a vital cell cycle regulator, dysregulation of which has been associated with a large number of human malignancies.One critic
会议
Objective: Ovarian cancer is one of the most lethal of woman cancers, and its clinical therapeutic effect is unsatisfied currently.Dinaciclib, a novel small molecule multi-CDKs inhibitor of CDK1/2/5/9
会议
Objective: Triptolide and celastrol are two most widely studied and promising compounds isolated from Thunder God Vime (Trypterigium wilfordii Hook F) with promising anticancer activity.However, their
会议
会议
Objective: Overexpression of ABCB1 (P-glycoprptein, P-gp) is one of the main reasons of multidrug resistance (MDR) in cancer cells.Trametinib, a small-molecule MEK kinase inhibitor, is currently used
会议
We have designed and tested a new way to selectively deliver HPMA polymer-coated adenovirus type 5 (Ad5) particles into matrix metalloproteinase (MMP)-overexpressing tumor cells.An activatable cell pe
会议